IGI Logo

Mankind Pharma is currently trading at Rs. 1895.00, up by 7.20 points or 0.38% from its previous closing of Rs. 1887.80 on the BSE.

The scrip opened at Rs. 1925.60 and has touched a high and low of Rs. 1925.60 and Rs. 1886.00 respectively. So far 3933 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 2039.95 on 21-Nov-2023 and a 52 week low of Rs. 1240.75 on 22-May-2023.

Last one week high and low of the scrip stood at Rs. 2037.75 and Rs. 1820.15 respectively. The current market cap of the company is Rs. 76432.27 crore.

The promoters holding in the company stood at 76.50%, while Institutions and Non-Institutions held 8.74% and 14.76% respectively.

Mankind Pharma has made investment of British pound sterling 999,900 in Actimed Therapeutics (Actimed) on December 15, 2023. It is a strategic investment in the field of treatment of cancer cachexia, amyotrophic lateral sclerosis and other muscle wasting disorders. Post this investment the aggregate shareholding of the Company in Actimed will be around 10.19%.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.